Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.61 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.61 |
| ▸ | TNF | P01375 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | HTT | P42858 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6879470 | 0.98 | TDP1 (0.68) | TDP1CYP11B1CYP11B2TNFLMNA | |
| Hydrochloric Acid SCHEMBL6093960 | 0.98 | TDP1 (0.68) | TDP1CYP11B1CYP11B2TNFLMNA | |
| Hydrochloric Acid SCHEMBL6946175 | 0.96 | TDP1 (0.66) | TDP1CYP11B1CYP11B2TNFLMNA | |
| SCHEMBL86384 | 0.85 | TDP1 (0.72) | TDP1CYP11B1CYP11B2TNFLMNA | |
| SCHEMBL825596 | 0.84 | TDP1 (0.78) | TDP1CYP11B1CYP11B2TNFLMNA | |
| SCHEMBL6851027 | 0.83 | TDP1 (0.70) | TDP1CYP11B1CYP11B2TNFLMNA | |
| SCHEMBL131657 | 0.83 | TDP1 (0.70) | TDP1CYP11B1CYP11B2TNFLMNA | |
| SCHEMBL3161153 | 0.83 | TDP1 (0.84) | TDP1CYP11B1CYP11B2TNFLMNA | |
| SCHEMBL30294105 | 0.83 | TDP1 (0.84) | TDP1CYP11B1CYP11B2TNFLMNA | |
| SCHEMBL9814242 | 0.83 | TDP1 (0.84) | TDP1CYP11B1CYP11B2TNFLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238176-A1 | ANTI-POLLUTION ECO-FRIENDLY MATERIAL AND METHOD FOR PREPARING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2024-07-18 | — | — | US | claimed |
| EP-3037166-A1 | ASYMMETRIC POROUS ADSORPTIVE BEAD | EMD Millipore Corporation (US) | 2016-06-29 | — | — | EP | claimed |
| US-9295928-B2 | Porous adsorptive or chromatographic media | EMD MILLIPORE CORPORATION (US) | 2016-03-29 | — | — | US | claimed |
| WO-2016029146-A1 | SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE | UNIVERSITY OF WASHINGTON (US) | 2016-02-25 | — | — | WO | claimed |
| US-20150060342-A1 | Porous Adsorptive Or Chromatographic Media | EMD MILLIPORE CORP (US) | 2015-03-05 | — | — | US | claimed |
| US-8697847-B2 | Protein purification using HCIC and ion exchange chromatography | MEDAREX, L.L.C. (US) | 2014-04-15 | — | — | US | claimed |
| US-20120165511-A1 | PROTEIN PURIFICATION USING HCIC AND ION EXCHANGE CHROMATOGRAPHY | MEDAREX, INC. | 2012-06-28 | — | — | US | claimed |
| US-8158196-B2 | Method of forming coated structures | EMD MILLIPORE CORPORATION (US) | 2012-04-17 | — | — | US | claimed |
| US-20110244127-A1 | METHOD OF FORMING COATED STRUCTURES | MILLIPORE CORPORATION (US) | 2011-10-06 | — | — | US | claimed |
| US-20110049042-A1 | Porous adsorptive or chromatographic media | MILLIPORE CORPORATION (US) | 2011-03-03 | — | — | US | claimed |
| US-5457096-A | Antibiotic | AMERICAN CYANAMID COMPANY (US) | 1995-10-10 | — | — | US | claimed |
| US-5442059-A | Antibiotics for mammalian and veterninary diseases | AMERICAN CYANAMID COMPANY (US) | 1995-08-15 | — | — | US | claimed |
| US-5420272-A | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1995-05-30 | — | — | US | claimed |
| EP-0618190-A1 | 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1994-10-05 | — | — | EP | claimed |
| US-5328902-A | Antibiotics | AMERICAN CYANAMID CO. (US) | 1994-07-12 | — | — | US | claimed |
| EP-0582788-A1 | 7-(Substituted)-9- (substituted glycyl)-amido)-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1994-02-16 | — | — | EP | claimed |
| EP-0582789-A1 | Novel 7-(substituted)-8-(substituted)-9- (substituted glycyl)amido -6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1994-02-16 | — | — | EP | claimed |
| EP-0582829-A1 | 9-(substituted glycyl) amido - 6-demethyl-6-deoxytetracyclines as antibiotic agents | AMERICAN CYANAMID COMPANY (US) | 1994-02-16 | — | — | EP | claimed |
| EP-0578745-A1 | PHOSPHORUS CONTAINING COMPOUNDS AS INHIBITORS OF RETROVIRUSES | THE UPJOHN COMPANY (US) | 1994-01-19 | — | — | EP | claimed |
| WO-1992017490-A1 | PHOSPHORUS CONTAINING COMPOUNDS AS INHIBITORS OF RETROVIRUSES | THE UPJOHN COMPANY (US) | 1992-10-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238176-A1 | ANTI-POLLUTION ECO-FRIENDLY MATERIAL AND METHOD FOR PREPARING THE SAME | CUTA, EXOSC9, EXOSC10 | TDP1 1890/4885CYP11B1 3816/4885CYP11B2 4055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.